Search

Vijay Shankar

Examiner (ID: 12272, Phone: (571)272-7682 , Office: P/2697 )

Most Active Art Unit
2624
Art Unit(s)
2614, 2624, 2673, 2777, 2607, 2629, 2622, 2697, 2778, 2605, 2775, 2787, 2743
Total Applications
2665
Issued Applications
2187
Pending Applications
287
Abandoned Applications
215

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17362669 [patent_doc_number] => 11229677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-25 [patent_title] => Antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition [patent_app_type] => utility [patent_app_number] => 16/300566 [patent_app_country] => US [patent_app_date] => 2017-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 6319 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300566 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/300566
Antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition Jan 8, 2017 Issued
Array ( [id] => 14326565 [patent_doc_number] => 10294286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Chimeric inhibitor molecules of complement activation [patent_app_type] => utility [patent_app_number] => 15/400412 [patent_app_country] => US [patent_app_date] => 2017-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 36867 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400412 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/400412
Chimeric inhibitor molecules of complement activation Jan 5, 2017 Issued
Array ( [id] => 11713613 [patent_doc_number] => 20170182113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'Crosslinked Peptide Hydrogels' [patent_app_type] => utility [patent_app_number] => 15/398379 [patent_app_country] => US [patent_app_date] => 2017-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 28568 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398379 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/398379
Crosslinked Peptide Hydrogels Jan 3, 2017 Abandoned
Array ( [id] => 14292003 [patent_doc_number] => 10286110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Crosslinked peptide hydrogels [patent_app_type] => utility [patent_app_number] => 15/398288 [patent_app_country] => US [patent_app_date] => 2017-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 80 [patent_no_of_words] => 26405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398288 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/398288
Crosslinked peptide hydrogels Jan 3, 2017 Issued
Array ( [id] => 14292005 [patent_doc_number] => 10286111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Crosslinked peptide hydrogels [patent_app_type] => utility [patent_app_number] => 15/398412 [patent_app_country] => US [patent_app_date] => 2017-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 80 [patent_no_of_words] => 26408 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398412 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/398412
Crosslinked peptide hydrogels Jan 3, 2017 Issued
Array ( [id] => 14324181 [patent_doc_number] => 10293083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Crosslinked peptide hydrogels [patent_app_type] => utility [patent_app_number] => 15/398254 [patent_app_country] => US [patent_app_date] => 2017-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 80 [patent_no_of_words] => 26416 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398254 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/398254
Crosslinked peptide hydrogels Jan 3, 2017 Issued
Array ( [id] => 13761189 [patent_doc_number] => 10172923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Use of endostatin peptides for the treatment of fibrosis [patent_app_type] => utility [patent_app_number] => 15/385705 [patent_app_country] => US [patent_app_date] => 2016-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 34 [patent_no_of_words] => 22693 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15385705 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/385705
Use of endostatin peptides for the treatment of fibrosis Dec 19, 2016 Issued
Array ( [id] => 13727983 [patent_doc_number] => 20180368459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => DIETARY PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/062429 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15050 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062429 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/062429
Dietary peptides Dec 15, 2016 Issued
Array ( [id] => 13606889 [patent_doc_number] => 20180354993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => CYCLIC NTCP-TARGETING PEPTIDES AND THEIR USES AS ENTRY INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/780129 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780129 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/780129
Cyclic NTCP-targeting peptides and their uses as entry inhibitors Dec 14, 2016 Issued
Array ( [id] => 17306302 [patent_doc_number] => 11207385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Melanocortins and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/077710 [patent_app_country] => US [patent_app_date] => 2016-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 30 [patent_no_of_words] => 24104 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077710 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/077710
Melanocortins and methods of use thereof Dec 13, 2016 Issued
Array ( [id] => 11663568 [patent_doc_number] => 20170152287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR SITE-SPECIFIC LABELING OF PEPTIDES AND PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/375759 [patent_app_country] => US [patent_app_date] => 2016-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33410 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15375759 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/375759
METHODS AND COMPOSITIONS FOR SITE-SPECIFIC LABELING OF PEPTIDES AND PROTEINS Dec 11, 2016 Abandoned
Array ( [id] => 16443670 [patent_doc_number] => 10835574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Modulators of complement activity [patent_app_type] => utility [patent_app_number] => 16/062653 [patent_app_country] => US [patent_app_date] => 2016-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 30274 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062653 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/062653
Modulators of complement activity Dec 6, 2016 Issued
Array ( [id] => 13733111 [patent_doc_number] => 20180371023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/060093 [patent_app_country] => US [patent_app_date] => 2016-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/060093
Muramyl peptide derivative compound, synthesis and uses thereof Dec 5, 2016 Issued
Array ( [id] => 16268845 [patent_doc_number] => 20200270332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => Means and Methods for Treating and Diagnosing Fibrosis or Fibrosis-associated Diseases [patent_app_type] => utility [patent_app_number] => 15/781028 [patent_app_country] => US [patent_app_date] => 2016-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781028 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/781028
Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases Dec 4, 2016 Issued
Array ( [id] => 16893194 [patent_doc_number] => 11034727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy [patent_app_type] => utility [patent_app_number] => 15/778626 [patent_app_country] => US [patent_app_date] => 2016-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 31 [patent_no_of_words] => 26510 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778626 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/778626
Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy Nov 23, 2016 Issued
Array ( [id] => 13049293 [patent_doc_number] => 10046023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => FC receptor (FcRn) binding peptides and uses thereof [patent_app_type] => utility [patent_app_number] => 15/354375 [patent_app_country] => US [patent_app_date] => 2016-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 44899 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354375 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/354375
FC receptor (FcRn) binding peptides and uses thereof Nov 16, 2016 Issued
Array ( [id] => 13589929 [patent_doc_number] => 20180346513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/775592 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775592 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/775592
METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF Nov 10, 2016 Abandoned
Array ( [id] => 13490195 [patent_doc_number] => 20180296640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => Peptides and Method for Treatment of Cardiac Arrest [patent_app_type] => utility [patent_app_number] => 15/769132 [patent_app_country] => US [patent_app_date] => 2016-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769132 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/769132
Peptides and method for treatment of cardiac arrest Nov 6, 2016 Issued
Array ( [id] => 11625909 [patent_doc_number] => 20170136099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY' [patent_app_type] => utility [patent_app_number] => 15/341383 [patent_app_country] => US [patent_app_date] => 2016-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8091 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15341383 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/341383
Surfactant protein D for the treatment of disorders associated with lung injury Nov 1, 2016 Issued
Array ( [id] => 17513695 [patent_doc_number] => 11292825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-05 [patent_title] => Protein conjugates [patent_app_type] => utility [patent_app_number] => 15/763857 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30546 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763857 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/763857
Protein conjugates Sep 29, 2016 Issued
Menu